ILMA Compoundings July 2018 - 17

The indirect reach of these designations, though, expands
the potential impact exponentially. Just as the 12 companies
received named designation based on their status as "owned
or controlled" by one or more of the seven named oligarchs,
the entities or operations owned or controlled by these 12
companies are also indirectly designated. Relationships and
activities with these downstream entities or operations are
equally off limits to any U.S. person, owned or controlled
entity (including non-U.S. subsidiaries), technology or
product. For example, if GAZ Group is contracted to produce commercial vehicles for Company B, a U.S. company,
then Company B is prohibited from continuing with the
purchase agreement.
As difficult a problem as that might be, it is at least
reasonably discoverable by Company B, affording it the
opportunity to avoid penalties under the sanction. But
imagine if Company B contracted to purchase the vehicles
from Company A in Canada, which is privately owned or
controlled by GAZ Group. In that case, Company B would
have the same penalty exposure and legal obligation, but it
would also have considerably more difficulty identifying the
connection with the sanction - and the related risk.
Far more difficult still are scenarios that might involve
indirect commercial relationships with one or more of the
designated companies through owned or controlled subsidiaries (or a series of them), including those outside the U.S.
From a U.S. corporate operating perspective, this could occur
even through sales to or purchases from a second- or thirdlevel subsidiary owned by one of the designated companies.
The ownership or control might not be public knowledge, so
the sanctions violation could be difficult to find. Deepening
the plight, the same scenario could involve a non-U.S. owned
or controlled subsidiary of the U.S. company. Either way, the
situation is just as prohibited as if the U.S. company directly
engaged with the designated company under the sanction.
But U.S. companies and individuals can also be affected
outside overt commercial operations, such as through
participation in investments (directly or through trusts,
401(k) plans and other indirect means) in stocks, bonds or
other securities issued by a company that is owned or controlled by one of the designated companies. For instance, a
401(k) plan might offer to its participants a corporate bond
investment product whose portfolio includes bonds issued
by Company Z, a European corporation that is owned or
controlled by GAZ Group through one or a series of owned
or controlled subsidiaries (such as GAZ Group privately
owning Company Y, which in turn controls the board of
Company X, which in turn controls the investment group

that owns 52 percent of Company Z). This hypothetical
investment product, and others with similar connections
to any of the designated companies or individuals, must be
divested and avoided.
IMMEDIATE DIVESTITURE REQUIRED
The most difficult part of the new sanctions is the immediacy of their application and the almost nonexistent
time afforded for corrective action. OFAC issued General
License 12C to allow a wind down of business operations,
contracts or other agreements (including importation of
goods, services or technology into the U.S.) with one of the
designated individuals or companies prior to June 5, 2018.
OFAC issued General License 13C to permit divestiture
or transfer of debt, equity or other holdings (including
necessary facilitation, clearing and settlement transactions)
in any of the following designated companies (or others they
own or control) by a non-U.S. person to another non-U.S.
person, prior to August 5, 2018: En+ Group PLC; GAZ
Group; and United Company RUSAL PLC.
If you or your company have any of the above wind-down
items (business operations, contracts or other agreements,
debt, equity or other holdings) and did not divest during the
corresponding window, you should consult counsel immediately to discuss your options, including potential voluntary
self-disclosure.
ALL COMMERCIAL DEALINGS REQUIRE DENIED
PARTY SCREENING AND EXTRA CAUTION
If comprehensive denied party screening is not part of your
company's diligence routine, that must change. But beyond
ordinary screening, additional precautions should be taken
to search out hidden prohibited ties that are not yet identified in screening lists and databases. Unfortunately, their
absence from the lists does not absolve anyone from penalty.
Investigations (external and internal) and formal reviews by
authorities are very expensive, and so are subsequent penalties if levied. Adding to the injury are the internal drain
on resources caused by the internal investigation, the review
process and the reputational impact that the publicity resulting from the scrutiny and potential legal action/penalty
assessment can cause. Measures like those announced April
6 substantially increase the exposure of U.S. companies and
their directors, officers and subsidiaries - including nonU.S. entities, no matter the ownership or control method.
Eggenschwiler, an ILMA consultant, is an international
trade attorney and director of Global Trade for the
Redstone Group LLC. He can be reached at
614-923-7472 or jeggenschwiler@redstonegrp.com.

17



ILMA Compoundings July 2018

Table of Contents for the Digital Edition of ILMA Compoundings July 2018

LETTER FROM THE CEO
INSIDE ILMA
WHAT’S COMING UP
INDUSTRY RUNDOWN
In the Know
International Insight
Market Report
HIGHER RATES, TIGHTER CAPACITY
BEARING FRUIT IN THE FOOD-GRADE LUBRICANTS MARKET
ACHIEVING PEAK PERFORMANCE
BUSINESS HUB
COUNSEL COMPOUND
WASHINGTON LANDSCAPE
IN NETWORK
Member Connections
Cross Connections
PORTRAIT
ILMA Compoundings July 2018 - Cover1
ILMA Compoundings July 2018 - Cover2
ILMA Compoundings July 2018 - 1
ILMA Compoundings July 2018 - 2
ILMA Compoundings July 2018 - LETTER FROM THE CEO
ILMA Compoundings July 2018 - INSIDE ILMA
ILMA Compoundings July 2018 - 5
ILMA Compoundings July 2018 - 6
ILMA Compoundings July 2018 - 7
ILMA Compoundings July 2018 - 8
ILMA Compoundings July 2018 - 9
ILMA Compoundings July 2018 - WHAT’S COMING UP
ILMA Compoundings July 2018 - 11
ILMA Compoundings July 2018 - INDUSTRY RUNDOWN
ILMA Compoundings July 2018 - 13
ILMA Compoundings July 2018 - 14
ILMA Compoundings July 2018 - In the Know
ILMA Compoundings July 2018 - International Insight
ILMA Compoundings July 2018 - 17
ILMA Compoundings July 2018 - Market Report
ILMA Compoundings July 2018 - 19
ILMA Compoundings July 2018 - HIGHER RATES, TIGHTER CAPACITY
ILMA Compoundings July 2018 - 21
ILMA Compoundings July 2018 - 22
ILMA Compoundings July 2018 - 23
ILMA Compoundings July 2018 - 24
ILMA Compoundings July 2018 - 25
ILMA Compoundings July 2018 - 26
ILMA Compoundings July 2018 - 27
ILMA Compoundings July 2018 - BEARING FRUIT IN THE FOOD-GRADE LUBRICANTS MARKET
ILMA Compoundings July 2018 - 29
ILMA Compoundings July 2018 - 30
ILMA Compoundings July 2018 - 31
ILMA Compoundings July 2018 - 32
ILMA Compoundings July 2018 - 33
ILMA Compoundings July 2018 - ACHIEVING PEAK PERFORMANCE
ILMA Compoundings July 2018 - 35
ILMA Compoundings July 2018 - 36
ILMA Compoundings July 2018 - 37
ILMA Compoundings July 2018 - BUSINESS HUB
ILMA Compoundings July 2018 - 39
ILMA Compoundings July 2018 - COUNSEL COMPOUND
ILMA Compoundings July 2018 - 41
ILMA Compoundings July 2018 - 42
ILMA Compoundings July 2018 - WASHINGTON LANDSCAPE
ILMA Compoundings July 2018 - Member Connections
ILMA Compoundings July 2018 - 45
ILMA Compoundings July 2018 - Cross Connections
ILMA Compoundings July 2018 - 47
ILMA Compoundings July 2018 - PORTRAIT
ILMA Compoundings July 2018 - Cover3
ILMA Compoundings July 2018 - Cover4
https://www.nxtbook.com/ygsreprints/ILMA/G127535ILMA_vol71_no7
https://www.nxtbook.com/ygsreprints/ILMA/G126213ILMA_vol71_no6
https://www.nxtbook.com/ygsreprints/ILMA/G125546_ILMA_vol71_no5
https://www.nxtbook.com/ygsreprints/ILMA/G124996_ILMA_vol71_no4
https://www.nxtbook.com/ygsreprints/ILMA/G123886_ILMA_vol71_no3
https://www.nxtbook.com/ygsreprints/ILMA/G123315_ILMA_vol71_no2
https://www.nxtbook.com/ygsreprints/ILMA/G122980_ILMA_vol71_no1
https://www.nxtbook.com/ygsreprints/ILMA/G121540_ILMA_vol70_no11
https://www.nxtbook.com/ygsreprints/ILMA/G120882_ILMA_vol70_no10
https://www.nxtbook.com/ygsreprints/ILMA/G120035_ILMA_vol70_no9
https://www.nxtbook.com/ygsreprints/ILMA/G121XXX_ILMA_vol70_no8
https://www.nxtbook.com/ygsreprints/ILMA/G120XXX_ILMA_vol70_no7
https://www.nxtbook.com/ygsreprints/ILMA/G119XXX_ILMA_vol70_no6
https://www.nxtbook.com/ygsreprints/ILMA/G118112_ILMA_vol70_no5
https://www.nxtbook.com/ygsreprints/ILMA/G117382_ILMA_vol70_no4
https://www.nxtbook.com/ygsreprints/ILMA/G116888_ILMA_vol70_no3
https://www.nxtbook.com/ygsreprints/ILMA/G115555_ILMA_vol70_no2
https://www.nxtbook.com/ygsreprints/ILMA/G114774_ILMA_vol70_no1
https://www.nxtbook.com/ygsreprints/ILMA/g110500_ILMA_vol69_no12
https://www.nxtbook.com/ygsreprints/ILMA/g110500_ILMA_vol69_no11
https://www.nxtbook.com/ygsreprints/ILMA/g110500_ILMA_vol69_no10
https://www.nxtbook.com/ygsreprints/ILMA/g109884_ILMA_vol69_no9
https://www.nxtbook.com/ygsreprints/ILMA/g109284_ILMA_vol69_no8
https://www.nxtbook.com/ygsreprints/ILMA/g108494_ILMA_vol69_no7
https://www.nxtbook.com/ygsreprints/ILMA/g107507_ILMA_vol69_no6
https://www.nxtbook.com/ygsreprints/ILMA/g106483_ILMA_vol69_no5
https://www.nxtbook.com/ygsreprints/ILMA/g105803_ILMA_vol69_no4
https://www.nxtbook.com/ygsreprints/ILMA/g104743_ILMA_vol69_no3
https://www.nxtbook.com/ygsreprints/ILMA/g103647_ILMA_vol69_no2
https://www.nxtbook.com/ygsreprints/ILMA/g102869_ILMA_vol69_no1
https://www.nxtbook.com/ygsreprints/ILMA/g101930_ILMA_vol68_no12
https://www.nxtbook.com/ygsreprints/ILMA/g100836_ILMA_vol68_no11
https://www.nxtbook.com/ygsreprints/ILMA/g99200_ILMA_vol68_no10
https://www.nxtbook.com/ygsreprints/ILMA/g98468_ILMA_vol68_no9
https://www.nxtbook.com/ygsreprints/ILMA/g97711_ILMA_vol68_no8
https://www.nxtbook.com/ygsreprints/ILMA/G96767ILMA_vol68_no7
https://www.nxtbook.com/ygsreprints/ILMA/G95397ILMA_vol65_no6
https://www.nxtbook.com/ygsreprints/ILMA/G94323ILMA_vol68_no5
https://www.nxtbook.com/ygsreprints/ILMA/G93127_ILMA_vol69_no4
https://www.nxtbook.com/ygsreprints/ILMA/G91785_ILMA_vol68_no3
https://www.nxtbook.com/ygsreprints/ILMA/G90956_ILMA_vol68_no2
https://www.nxtbook.com/ygsreprints/ILMA/G89146_ILMA_vol68_no1
https://www.nxtbook.com/ygsreprints/ILMA/G87981_ILMA_vol67_no12
https://www.nxtbook.com/ygsreprints/ILMA/G85409_ILMA_vol67_no11
https://www.nxtbook.com/ygsreprints/ILMA/G83595_ILMA_vol67_no10
https://www.nxtbook.com/ygsreprints/ILMA/G81672_ILMA_vol67_no9
https://www.nxtbook.com/ygsreprints/ILMA/G80238_ILMA_vol7_no8
https://www.nxtbook.com/ygsreprints/ILMA/G79388_ILMA_vol7_no7
https://www.nxtbook.com/ygsreprints/ILMA/G78361_ILMA_vol7_no6
https://www.nxtbook.com/ygsreprints/ILMA/G77448_ILMA_vol7_no5
https://www.nxtbook.com/ygsreprints/ILMA/G75899_ILMA_vol67_no4
https://www.nxtbook.com/ygsreprints/ILMA/G75036_ILMA_vol67_no3
https://www.nxtbook.com/ygsreprints/ILMA/G72720_ILMA_vol67_no2
https://www.nxtbook.com/ygsreprints/ILMA/G72220_ILMA_vol67_no1
https://www.nxtbook.com/ygsreprints/ILMA/G70970_ILMA_vol66_no12
https://www.nxtbook.com/ygsreprints/ILMA/G69813_ILMA_vol66_no11
https://www.nxtbook.com/ygsreprints/ILMA/G67522_ILMA_vol66_no10
https://www.nxtbook.com/ygsreprints/ILMA/G66343_ILMA_vol66_no9
https://www.nxtbook.com/ygsreprints/ILMA/G64859_ILMA_vol66_no8
https://www.nxtbookmedia.com